Government Cuts Prices of 1,364 Cancer Drugs, Saving ₹3,540 Crore Annually
The government has revised prices for 1,364 anti-cancer drug formulations effective November 9 to limit trade margins and reduce costs for consumers. This price revision is expected to save consumers approximately ₹3,540.38 crore annually, making cancer treatment more affordable across the country.
Economic Times·



